Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Hyperlactatemia and concurrent use of antiretroviral therapy among HIV infected patients in Uganda.

Waiswa M, Byarugaba BB, Ocama P, Mayanja-Kizza H, Seremba E, Ganguli S, Crowther M, Colebunders R.

Afr Health Sci. 2012 Sep;12(3):268-75.

2.

Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.

Noguera A, Fortuny C, Sanchez E, Artuch R, Vilaseca MA, Muñoz-Almagro C, Pou J, Jiménez R.

Pediatr Infect Dis J. 2003 Sep;22(9):778-82.

PMID:
14506367
3.

Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients.

Marceau G, Sapin V, Jacomet C, Ughetto S, Cormerais L, Regagnon C, Dastugue B, Peigue-Lafeuille H, Beytout J, Laurichesse H.

Clin Chem. 2003 Jul;49(7):1154-62.

4.

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.

John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA.

AIDS. 2001 Apr 13;15(6):717-23.

PMID:
11371686
5.
6.

Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.

Manosuthi W, Prasithsirikul W, Chumpathat N, Suntisuklappon B, Athichathanabadi C, Chimsuntorn S, Sungkanuparph S.

Int J Infect Dis. 2008 Nov;12(6):582-6. doi: 10.1016/j.ijid.2007.12.005. Epub 2008 Mar 11.

7.

Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?

Imhof A, Ledergerber B, Günthard HF, Haupts S, Weber R; Swiss HIV Cohort Study.

Clin Infect Dis. 2005 Sep 1;41(5):721-8. Epub 2005 Jul 29.

PMID:
16080096
8.

Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?

Soler-Palacín P, Martín-Nalda A, Martínez-Gómez X, Melendo S, Riudor E, Arranz JA, Espiau M, Figueras C.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):752-8. doi: 10.1089/AID.2011.0198. Epub 2011 Nov 16.

PMID:
22010980
9.

Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.

Moyle GJ, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard BG.

AIDS. 2002 Jul 5;16(10):1341-9. Erratum in: AIDS. 2002 Aug 16;16(12):1708.

PMID:
12131210
10.

Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting.

Pérez EH, Dawood H, Chetty U, Esterhuizen TM, Bizaare M.

Int J Infect Dis. 2008 Sep;12(5):553-6. doi: 10.1016/j.ijid.2008.03.007. Epub 2008 Jun 3.

12.

Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity.

Wohl DA, Pilcher CD, Evans S, Revuelta M, McComsey G, Yang Y, Zackin R, Alston B, Welch S, Basar M, Kashuba A, Kondo P, Martinez A, Giardini J, Quinn J, Littles M, Wingfield H, Koletar SL; Adult AIDS Clinical Trials Group A5129 Team.

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):274-8.

PMID:
15076242
13.

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.

Boubaker K, Flepp M, Sudre P, Furrer H, Haensel A, Hirschel B, Boggian K, Chave JP, Bernasconi E, Egger M, Opravil M, Rickenbach M, Francioli P, Telenti A.

Clin Infect Dis. 2001 Dec 1;33(11):1931-7. Epub 2001 Oct 23.

PMID:
11692306
14.

Blood lactate in HIV-infected children on antiretroviral therapy in rural South Africa.

van Ramshorst MS, Struthers HE, McIntyre JA, Peters RP.

Pediatr Infect Dis J. 2014 Apr;33(4):393-5. doi: 10.1097/INF.0000000000000036.

PMID:
23995586
15.
16.

First-line therapy and mitochondrial damage: different nucleosides, different findings.

Blanco F, García-Benayas T, José de la Cruz J, González-Lahoz J, Soriano V.

HIV Clin Trials. 2003 Jan-Feb;4(1):11-9.

PMID:
12577192
17.

Management of hyperlactatemia: no need for routine lactate measurements.

Brinkman K.

AIDS. 2001 Apr 13;15(6):795-7. No abstract available.

PMID:
11371695
18.

Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.

Jantarapakde J, Phanuphak N, Chaturawit C, Pengnonyang S, Mathajittiphan P, Takamtha P, Dungjun N, Pinyakorn S, Pima W, Prasithsirikul W, Phanuphak P.

AIDS Patient Care STDS. 2014 Jul;28(7):331-40. doi: 10.1089/apc.2013.0294. Epub 2014 Jun 10.

PMID:
24914459
19.

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS.

N Engl J Med. 2002 Mar 14;346(11):811-20.

20.

Supplemental Content

Support Center